Literature DB >> 17719372

Triamcinolone acetonide in ocular therapeutics.

C M Jermak1, J T Dellacroce, J Heffez, G A Peyman.   

Abstract

Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years. Its use has increased dramatically in recent years for periocular and intraocular treatment of retinal vasculature disease and uveitis. This comprehensive review discusses the pharmacokinetics of triamcinolone acetonide and summarizes its uses in a number of diseases, both intraocular and extraocular. It discusses side effects and their management. Finally, it discusses the controversy over its use.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17719372     DOI： 10.1016/j.survophthal.2007.06.004

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN： 0039-6257            Impact factor:   6.048


  32 in total

1.  The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment.

Authors:  Y Wang; V M Wang; C-C Chan
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

2.  Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.

Authors:  Ebenezer Daniel; Maxwell Pistilli; Srishti Kothari; Naira Khachatryan; R Oktay Kaçmaz; Sapna S Gangaputra; H Nida Sen; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum; Grace A Levy-Clarke; Nirali P Bhatt; John H Kempen
Journal:  Ophthalmology       Date:  2017-04-19       Impact factor: 12.079

3.  Purified triamcinolone acetonide as antifibrotic adjunct in glaucoma filtering surgery.

Authors:  Barend Frits Theodorus Hogewind; Benjamin Pijl; Carel Benedict Hoyng; Thomas Theelen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-29       Impact factor: 3.117

4.  Diagnosis and treatment of myopic traction maculopathy.

Authors:  Ping-Bo Ouyang; Xuan-Chu Duan; Xiao-Hua Zhu
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

5.  Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA) based nanoparticles for controlled drug delivery: Effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles.

Authors:  Viral Tamboli; Gyan P Mishra; Ashim K Mitra
Journal:  Colloid Polym Sci       Date:  2013-05-01       Impact factor: 1.931

6.  Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus.

Authors:  Rosana Gerometta; Maria-Grazia Spiga; Teresa Borrás; Oscar A Candia
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

Review 7.  Intraocular sustained-release delivery systems for triamcinolone acetonide.

Authors:  Saffar Mansoor; Baruch D Kuppermann; M Cristina Kenney
Journal:  Pharm Res       Date:  2009-01-28       Impact factor: 4.200

8.  Intravitreal triamcinolone for intraocular inflammation and associated macular edema.

Authors:  Steven M Couch; Sophie J Bakri
Journal:  Clin Ophthalmol       Date:  2009-06-02

9.  Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.

Authors:  Wenchang Li; Bing He; Wenbing Dai; Qiang Zhang; Yuling Liu
Journal:  Int Ophthalmol       Date:  2013-07-19       Impact factor: 2.031

10.  Comparative Effectiveness of Three Prophylactic Strategies to Prevent Clinical Macular Edema after Phacoemulsification Surgery.

Authors:  Neal H Shorstein; Liyan Liu; Michael D Waxman; Lisa J Herrinton
Journal:  Ophthalmology       Date:  2015-09-26       Impact factor: 12.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.